Edgewell Personal Care (EPC) 10-Q8 Feb 182018 Q1 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Dec. 31, 2017	Jan. 31, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Central Index Key	1,096,752
Current Fiscal Year End Date	--09-30
Entity Filer Category	Large Accelerated Filer
Trading Symbol	EPC
Document Type	10-Q
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		53,997,612

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net sales	$ 468.3	$ 485
Cost of products sold	268	257
Gross profit	200.3	228
Selling, general and administrative expense	97.2	93.8
Advertising and sales promotion expense	49	50.6
Research and development expense	16.1	16.3
Gain on sale of Playtex gloves	(15.9)	0
Restructuring charges	0	6.9
Interest expense associated with debt	17.8	17.4
Other expense (income), net	3	(1.9)
Earnings before income taxes	33.1	44.9
Income tax provision	26.4	11.4
Net earnings	$ 6.7	$ 33.5
Basic net earnings per share (in usd per share)	$ 0.12	$ 0.58
Diluted net earnings per share (in usd per share)	$ 0.12	$ 0.58
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 6.7	$ 33.5
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	9.5	(38.7)
Pension and postretirement activity, net of tax	0.4	3.9
Deferred (loss) gain on hedging activity, net of tax	0.2	7.9
Total other comprehensive income (loss), net of tax	10.1	(26.9)
Total comprehensive income	$ 16.8	$ 6.6

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Pension and postretirement activity, tax	$ 0.3	$ 1.9
Deferred (loss) gain on hedging activity, tax	$ 0.1	$ 4.1

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2017	Sep. 30, 2017
Current assets
Cash and cash equivalents	$ 529.9	$ 502.9
Trade receivables, less allowance for doubtful accounts	183.1	224.1
Inventories	349.3	333.5
Other current assets	118.3	125.7
Total current assets	1,180.6	1,186.2
Property, plant and equipment, net	441.9	453.4
Goodwill	1,447.8	1,445.9
Other intangible assets, net	1,068.6	1,071.7
Other assets	33.6	31.6
Total assets	4,172.5	4,188.8
Current liabilities
Current maturities of long-term debt	0	0
Notes payable	21.1	19.4
Accounts payable	198.8	223.6
Other current liabilities	225.5	281.4
Total current liabilities	445.4	524.4
Long-term debt	1,678.7	1,525.4
Deferred income tax liabilities	143.9	181.8
Other liabilities	248.7	215.5
Total liabilities	2,516.7	2,447.1
Shareholders' equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,620.7	1,623.4
Retained earnings	969.2	952.9
Common shares in treasury at cost	(813.5)	(703.9)
Accumulated other comprehensive loss	(121.3)	(131.4)
Total shareholders' equity	1,655.8	1,741.7
Total liabilities and shareholders' equity	$ 4,172.5	$ 4,188.8

Condensed Consolidated Balance5

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2017	Sep. 30, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5.4	$ 4.3
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	54,151,058	56,017,537
Treasury shares (in shares)	11,100,931	9,234,452

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flow from Operating Activities
Net earnings	$ 6.7	$ 33.5
Non-cash restructuring costs	0	1.7
Depreciation and amortization	24.8	23.4
Share-based compensation expense	4.8	5.7
(Gain) / loss on sale of assets	(13.9)	1.8
Deferred income taxes	(28.9)	(0.7)
Other, net	(4.8)	(5.7)
Changes in operating assets and liabilities	(9.7)	(111.6)
Net cash used by operating activities	(21)	(51.9)
Cash Flow from Investing Activities
Capital expenditures	(11.6)	(13.7)
Acquisitions, net of cash acquired	0	(34)
Playtex gloves sale	19	0
Proceeds from sale of assets	2.1	0
Net cash from (used by) investing activities	9.5	(47.7)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	253	146
Cash payments on debt with original maturities greater than 90 days	(100)	(287)
Net decrease in debt with original maturities of 90 days or less	(1.3)	(0.4)
Common shares purchased	(115.2)	(58)
Employee shares withheld for taxes	(2)	(7.1)
Net cash from (used by) financing activities	34.5	(206.5)
Effect of exchange rate changes on cash	4	(14.3)
Net increase (decrease) in cash and cash equivalents	27	(320.4)
Cash and cash equivalents, beginning of period	502.9	738.9
Cash and cash equivalents, end of period	$ 529.9	$ 418.5

Background and Basis of Present

Background and Basis of Presentation	3 Months Ended
Background and Basis of Presentation	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell" or the "Company"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. Edgewell has a portfolio of over 25 brands and a global footprint in more than 50 countries. The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Bulldog® men's skin care products, Wet Ones® wipes and Playtex® household gloves until the sale of the gloves business in October 2017. Refer to Note 2 for additional details on the sale of the Playtex household gloves business. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand. • All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP"), under the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 20, 2017. Recently Adopted Accounting Pronouncements. In August 2014, the Financial Accounting Standards Board ("FASB") issued a new Accounting Standards Update ("ASU"), which requires management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. The Company adopted this guidance as of October 1, 2017 and noted the adoption did not have an impact on the financial statements or the related disclosures. In July 2015, the FASB issued a new ASU, which aligns the measurement of inventory under GAAP more closely with International Financial Reporting Standards. Under the new guidance, an entity that measures inventory using FIFO or average cost should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this guidance on a prospective basis as of October 1, 201 7 and noted the adoption did not have a material impact on the financial statements or the related disclosures. In March 2016, the FASB issued an ASU which simplifies several aspects of the accounting for share-based payment transactions, including requiring excess tax benefits and tax deficiencies to be recognized as income tax benefits or expenses in the consolidated statement of earnings. The standard requires cash flows from excess tax benefits and deficiencies, previously classified as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted these provisions of the guidance prospectively in the first quarter of fiscal 2018. As a result, the Company recognized excess tax deficiencies of $0.6 through income taxes during the first quarter of fiscal 2018 rather than additional paid-in capital. The excess tax deficiencies were recorded as an operating activity in the Condensed Consolidated Statement of Cash Flows during the first quarter of 2018. Also, as part of the adoption, a $9.7 adjustment was recorded to increase retained earnings and deferred tax assets to recognize the cumulative amount of previously unrecognized excess tax benefits as of October 1, 2017. Additionally, the ASU requires the presentation of employee taxes paid when an employer withholds shares for tax withholding purposes to be presented as a financing activity in the statement of cash flows as opposed to as an operating activity. This aspect of the new guidance was required to be adopted retrospectively. As such, $7.1 of cash outflows for tax withholding payments were reclassified from an operating activity to a financing activity in the Condensed Consolidated Statement of Cash Flows for the first quarter of fiscal 2017. Finally, under the ASU, the Company elected to record forfeitures as they occur. This election did not have a material impact on the financial statements. Recently Issued Accounting Pronouncements. In May 2014, the FASB issued an ASU, which provides a single comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries and across capital markets. During 2016, the FASB issued three ASUs, clarifying the revenue recognition implementation guidance on various topics included within the original ASU. The new guidance will be effective for the Company beginning October 1, 2018, with the option of using either a full retrospective or modified retrospective method. The Company is still evaluating the method of adoption. During fiscal 2017, the Company established a cross-functional implementation team, including representatives from all of its businesses globally, to analyze the current processes in place for the recognition of revenue and identify potential differences that would result from application of the new guidance. This initial assessment includes analysis of significant types of arrangements, processes and systems, and reviews of representative contracts. Additionally, the Company has begun reviewing the enhanced disclosure requirements under the new standard. Revenues are primarily generated from the sale of finished products to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. While the assessment is not complete, the timing of revenue recognition is not expected to be materially impacted by the new standard. The Company is still assessing the impact of the standard on its consolidated financial statements and on related disclosures. No other new accounting pronouncement issued or effective during the fiscal year which was not previously disclosed in our Annual Report on Form 10-K had or is expected to have a material impact on our consolidated financial statements or related disclosures.

Divestiture

Divestiture	3 Months Ended
Divestiture	Dec. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
Divestiture	Divestiture On October 3, 2017, the Company entered into an agreement to sell its Playtex® gloves business to a household products company (the “Acquirer”) for $19.0 to allow the Company to better focus and utilize its resources on its other product lines. The agreement also provided the Acquirer with indefinite and exclusive worldwide rights to the Playtex trademark for gloves. The sale was completed on October 26, 2017. Total assets sold were approximately $3.1 resulting in a pre-tax gain on sale of $15.9 .

Restructuring Charges

Restructuring Charges	3 Months Ended
Restructuring Charges	Dec. 31, 2017
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Restructuring In November 2012, the Company's Board of Directors (the "Board") authorized an enterprise-wide restructuring plan (the "Restructuring"). The Restructuring originally included several initiatives focused on reducing costs in general and administrative functions, as well as reducing manufacturing and operating costs associated with the Company's discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges have primarily related to plant closure, accelerated depreciation charges, severance and related benefit costs. Restructuring costs under this plan totaled $170.1 . Due to an increase in Wet Shave footprint costs and a delay in the transition of manufacturing in the Company's Feminine Care segment from Montreal to Dover, Delaware, some anticipated savings are not expected to be realized until fiscal 2019. The Company does not expect costs in fiscal 2018 or in future periods to be material. Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave and Feminine Care segments for the three months ended December 31, 2016. The Company does not include restructuring costs in the results of its reportable segments. Three Months Ended December 31, 2016 Wet Feminine Total Restructuring Severance and related benefit costs $ 0.4 $ 1.5 $ 1.9 Asset impairment and accelerated depreciation — 1.7 1.7 Consulting, program management and other exit costs 1.7 1.6 3.3 Total Restructuring $ 2.1 $ 4.8 $ 6.9 In addition, pre-tax costs of $0.3 for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring were included in Cost of products sold. During the first quarter of fiscal 2018, the Company made severance and related benefit payments of $0.7 . The remaining restructuring accrual was $1.7 for severance and related benefit costs as of December 31, 2017. The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2017: Utilized October 1, 2016 Charge to Other (1) Cash Non-Cash September 30, 2017 Restructuring Severance and termination related costs $ 16.7 $ 6.5 $ (0.3 ) $ (20.5 ) $ — $ 2.4 Asset impairment and accelerated depreciation — 6.9 — — (6.9 ) — Other related costs — 16.2 — (16.2 ) — — Total Restructuring $ 16.7 $ 29.6 $ (0.3 ) $ (36.7 ) $ (6.9 ) $ 2.4 (1) Includes the impact of currency translation.

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended December 31, 2017, the Company had income tax expense of $26.4 on Earnings before income taxes of $33.1 . The effective tax rate for the three months ended December 31, 2017 was 79.8% . The difference between the federal statutory rate and the effective rate is primarily due to a $16.2 net transitional charge resulting from the enactment of The Tax Cuts and Jobs Act ("the Tax Act"), as discussed below. The rate was also affected by unfavorable tax adjustments, including the impact of the new share-based payment guidance and changes to prior year provision estimates, which increased the effective rate by 5% . For the three months ended December 31, 2016, the Company had income tax expense of $11.4 on Earnings before income taxes of $44.9 . The effective tax rate for the three months ended December 31, 2016 was 25.4% . The difference between the federal statutory rate and the effective rate was due to a higher mix of earnings in lower tax rate jurisdictions and was favorably impacted by Spin costs and Restructuring charges in higher tax rate jurisdictions. In addition, the effective tax rate was impacted by favorable tax adjustments, which reduced the effective rate by approximately 4% . U.S. Tax Reform On December 22, 2017, the U.S. government enacted the Tax Act. This new comprehensive tax legislation reduces the U.S. federal corporate tax rate from 35% to 21% but also limits and/or eliminates certain deductions while creating new taxes on certain foreign sourced earnings. Since the Company has a September 30 fiscal year end, the lower U.S. corporate income tax rate will be phased in, resulting in a blended U.S. statutory federal rate of approximately 24.5% for the fiscal year ending September 30, 2018 and 21% for subsequent fiscal years. The reduction in the U.S. corporate tax rate requires the Company to remeasure its U.S. deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which can be 24.5% or 21% . The Tax Act also imposed a one-time transition tax on historical earnings of certain foreign subsidiaries that were not previously taxed by the U.S. Due to the Company’s fiscal year end, certain tax provisions of the new Tax Act will impact the Company in fiscal 2018 while others will be effective in subsequent years. For the quarter ended December 31, 2017 (period of enactment), the estimated impact of the one-time transition tax on foreign earnings was $97.2 , offset by the estimated benefit of remeasurement of U.S. deferred tax assets and liabilities of $81 . The net impact of these transitional provisions resulted in a net charge of $16.2 for the quarter, which was included as a component of income tax expense. The Company has tax loss carryforwards and tax credits, a portion of which are expected be used to partially offset amounts payable over 8 years related to the one-time transition tax on foreign earnings. The tax law changes included in the Tax Act are broad and complex. The estimates of the transition impact of the Tax Act, as discussed above, are provisional. The final impact may differ from those estimates, possibly materially, due to, among other things, changes in interpretation of the Tax Act, legislative action to address questions that arise because of the Tax Act, changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or updates or changes to estimates the Company used to calculate the transition impacts, including impacts from changes to earnings estimates, foreign income tax estimates and foreign exchange rates. The Securities and Exchange Committee ("SEC") has issued rules under SAB 118 that would allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. The Company generally repatriates a portion of current year earnings from select non-US subsidiaries only if the economic cost of the repatriation is not considered material. As a result of the Tax Act, the Company expects to repatriate a significant amount of cash from foreign subsidiaries. The Company is currently evaluating the amount and expected uses of repatriated cash. The Company does not expect the incremental cost of repatriating cash to be material.

Earnings per Share

Earnings per Share	3 Months Ended
Earnings per Share	Dec. 31, 2017
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent ("RSE") awards. Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended December 31, 2017 2016 Basic weighted-average shares outstanding 55.4 57.7 Effect of dilutive securities: RSE awards 0.2 0.4 Total dilutive securities 0.2 0.4 Diluted weighted-average shares outstanding 55.6 58.1 For the three months ended December 31, 2017 and 2016, the calculation of diluted weighted-average shares outstanding excludes 0.6 of share options because the effect of including these awards was anti-dilutive. For the three months ended December 31, 2017 and 2016, the number of RSE awards considered anti-dilutive was immaterial.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
Goodwill and Intangible Assets	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Balance at October 1, 2017 $ 971.2 $ 195.6 $ 209.5 $ 69.6 $ 1,445.9 Cumulative translation adjustment 2.1 0.1 (0.3 ) — 1.9 Balance at December 31, 2017 $ 973.3 $ 195.7 $ 209.2 $ 69.6 $ 1,447.8 Total amortizable intangible assets were as follows: December 31, 2017 September 30, 2017 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 189.3 $ 18.3 $ 171.0 $ 188.6 $ 16.0 $ 172.6 Technology and patents 78.0 75.3 2.7 77.9 74.4 3.5 Customer related and other 151.6 91.2 60.4 151.5 89.8 61.7 Total amortizable intangible assets $ 418.9 $ 184.8 $ 234.1 $ 418.0 $ 180.2 $ 237.8 Amortization expense was $4.4 and $4.0 for the three months ended December 31, 2017 and 2016, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2018 and for fiscal 2019, 2020, 2021, 2022 and 2023 is $11.7 , $14.8 , $14.2 , $13.6 , $13.5 and $13.5 , respectively, and $152.8 thereafter. The Company had indefinite-lived intangible assets of $834.5 ( $185.1 in Wet Shave, $475.7 in Sun and Skin Care, $29.9 in Feminine Care and $143.8 in All Other) at December 31, 2017 , an increase of $0.6 from September 30, 2017, related to changes in foreign currency translation rates. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. The Company continuously monitors events which could trigger an interim impairment analysis, such as changing business conditions and environmental factors. The Company's stock price has declined since September 30, 2017. A prolonged decrease in the Company's stock price could be an indication of a triggering event. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. Refer to the sensitivity analysis in Note 8 to the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 20, 2017. During fiscal 2017, the Company recorded impairment charges of $312.0 and $7.0 on its Playtex and Edge brand names, respectively. The impairment of Playtex and Edge in fiscal 2017 was the result of intense competition in the Feminine Care and Wet Shave segments which resulted in decreased market share. Based on the impairment taken and continued competitive pressure on the Playtex and Edge brands, the intangible assets associated with the brand names were converted to definite-lived assets as of July 1, 2017 and assigned a useful life of 20 years. The conversion of the Playtex and Edge brand names to definite-lived intangible assets increased amortization expense by $1.8 for the three months ended December 31, 2017.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	3 Months Ended
Supplemental Balance Sheet Information	Dec. 31, 2017
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information December 31, September 30, Inventories Raw materials and supplies $ 52.2 $ 50.6 Work in process 61.3 60.9 Finished products 235.8 222.0 Total inventories $ 349.3 $ 333.5 Other Current Assets Miscellaneous receivables $ 13.7 $ 16.9 Prepaid expenses 64.8 55.6 Value added tax collectible from customers 20.3 25.2 Income taxes receivable 16.7 24.7 Other 2.8 3.3 Total other current assets $ 118.3 $ 125.7 Property, Plant and Equipment Land $ 19.5 $ 19.3 Buildings 142.5 139.1 Machinery and equipment 956.3 947.4 Capitalized software costs 45.3 42.3 Construction in progress 41.8 49.7 Total gross property, plant and equipment 1,205.4 1,197.8 Accumulated depreciation and amortization (763.5 ) (744.4 ) Total property, plant and equipment, net $ 441.9 $ 453.4 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 41.4 $ 32.2 Accrued trade allowances 21.2 24.6 Accrued salaries, vacations and incentive compensation 27.1 40.6 Income taxes payable 10.6 18.3 Returns reserve 27.3 53.3 Restructuring reserve 1.7 3.0 Value added tax payable 5.1 5.8 Deferred compensation 15.3 13.8 Other 75.8 89.8 Total other current liabilities $ 225.5 $ 281.4 Other Liabilities Pensions and other retirement benefits $ 106.6 $ 109.4 Deferred compensation 42.1 47.3 Long-term income taxes payable 41.4 — Other non-current liabilities 58.6 58.8 Total other liabilities $ 248.7 $ 215.5

Accounts Receivable Facility

Accounts Receivable Facility	3 Months Ended
Accounts Receivable Facility	Dec. 31, 2017
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facility On September 15, 2017, the Company entered into a $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser. Transfers under this agreement are accounted for as sales of receivables, resulting in the receivables being de-recognized from the consolidated balance sheet. As of December 31, 2017, the discount rate used to determine the purchase price for the subject receivables is based upon LIBOR plus a margin applicable to the specified obligor. Account receivables sold under this agreement for the quarter ended December 31, 2017 were $210.1 . The trade receivables sold that remained outstanding under this agreement as of December 31, 2017 and September 30, 2017 were $74.6 and $81.7 , respectively. The dilution reserve, which represents the Company's retained interest in sold receivables, was $7.5 and $8.2 as of December 31, 2017 and September 30, 2017, respectively, and was recognized on the Consolidated Balance Sheets as a receivable. The difference between the carrying amount of the trade receivables sold and the sum of the cash received was recorded as a loss on sale of receivables in Other expense (income), net in the Consolidated Statement of Earnings. For the three months ended December 31, 2017, the loss on sale of trade receivables was $0.4 .

Debt

Debt	3 Months Ended
Debt	Dec. 31, 2017
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: December 31, September 30, Senior notes, fixed interest rate of 4.7%, due 2021, net (1) $ 598.4 $ 598.3 Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2) 497.6 497.4 U.S. revolving credit facility due 2020 398.0 245.0 Term loan, due 2019, net (1) 184.7 184.7 Total long-term debt, including current maturities 1,678.7 1,525.4 Less current portion — — Total long-term debt $ 1,678.7 $ 1,525.4 (1) At December 31, 2017 , the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.6 , $1.8 and $0.3 , respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7 , $1.9 and $0.3 , respectively. (2) At December 31, 2017 and September 30, 2017, the balance for the senior notes due 2022 was reflected net of discount of $0.6 and $0.7 , respectively. The Company had outstanding, variable-rate international borrowings, recorded in Notes payable, of $21.1 and $19.4 as of December 31, 2017 and September 30, 2017 , respectively.

Retirement Plans

Retirement Plans	3 Months Ended
Retirement Plans	Dec. 31, 2017
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows: Three Months Ended December 31, 2017 2016 Service cost $ 1.5 $ 1.8 Interest cost 4.3 3.8 Expected return on plan assets (7.9 ) (7.9 ) Recognized net actuarial loss 1.1 1.5 Settlement loss recognized — 0.3 Net periodic (benefit) cost $ (1.0 ) $ (0.5 )

Shareholders' Equity

Shareholders' Equity	3 Months Ended
Shareholders' Equity	Dec. 31, 2017
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Shareholders' Equity In January 2018, the Board approved an authorization to repurchase up to 10.0 shares of the Company's common stock, replacing the previous stock repurchase authorization from May 2015, when the Board approved an authorization to repurchase up to 10.0 shares of the Company's common stock. During the three months ended December 31, 2017 , the Company repurchased 1.9 shares of its common stock for $115.2 , all of which were purchased under the previous authorization from May 2015. The full 10.0 shares authorized by the Board in January 2018 are available for future share repurchases. Any future share repurchases would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors. During the three months ended December 31, 2017 , the Company paid $0.1 cash dividends related to the vesting of RSE awards, which had been declared and accrued during prior fiscal years. The Company has not declared any dividends since the third quarter of fiscal 2015, and does not currently intend to declare dividends in the foreseeable future.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
Accumulated Other Comprehensive Loss	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive (Loss) Income The following table presents the changes in accumulated other comprehensive (loss) income ("AOCI"), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2017 $ (29.0 ) $ (101.3 ) $ (1.1 ) $ (131.4 ) OCI before reclassifications (1) 9.5 (0.3 ) (0.3 ) 8.9 Reclassifications to earnings — 0.7 0.5 1.2 Balance at December 31, 2017 $ (19.5 ) $ (100.9 ) $ (0.9 ) $ (121.3 ) Foreign Pension and Hedging Total Balance at October 1, 2016 $ (68.1 ) $ (126.3 ) $ (2.8 ) $ (197.2 ) OCI before reclassifications (1) (38.7 ) 2.7 7.7 (28.3 ) Reclassifications to earnings — 1.2 0.2 1.4 Balance at December 31, 2016 $ (106.8 ) $ (122.4 ) $ 5.1 $ (224.1 ) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: For the Three Months Ended Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2017 2016 Loss / (gain) on cash flow hedges Foreign exchange contracts $ 0.7 $ 0.3 Other (income) expense, net 0.7 0.3 Total before tax (0.2 ) (0.1 ) Tax expense 0.5 0.2 Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses 1.1 1.5 (1) Settlement loss recognized — 0.3 (1) 1.1 1.8 Total before tax (0.4 ) (0.6 ) Tax expense 0.7 1.2 Net of tax Total reclassifications for the period $ 1.2 $ 1.4 Net of tax (1) These AOCI components are included in the computation of net periodic (benefit) cost. See Note 10 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	3 Months Ended
Financial Instruments and Risk Management	Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management At times, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties and its counterparty netting arrangements. The section below outlines the types of derivatives that existed at December 31, 2017 and September 30, 2017 , as well as the Company's objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company's sales are tied to currencies other than the U.S. dollar, the Company's reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact to reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the Euro, the Japanese Yen, the British Pound, the Canadian Dollar, the Czech Koruna and the Australian Dollar. Additionally, the Company's foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary's local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary's local currency results in an exchange gain or loss recorded in Other expense (income), net. The primary currency to which the Company's foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges At December 31, 2017 , the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective for accounting purposes in offsetting the associated risk. The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had unrealized pre-tax losses of $1.3 and $1.6 at December 31, 2017 and September 30, 2017 , respectively, on these forward currency contracts accounted for as cash flow hedges, which are included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at December 31, 2017 levels over the next twelve months, the majority of the pre-tax loss included in AOCI at December 31, 2017 is expected to be included in Other (income) expense, net. Contract maturities for these hedges extend into fiscal 2019. There were 63 open foreign currency contracts at December 31, 2017 with a total notional value of $129.8 . Derivatives not Designated as Hedges The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures, thus they are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three months ended December 31, 2017 resulted in a loss of $0.2 , compared to a gain of $3.5 for the three months ended December 31, 2016, and was recorded in Other expense (income), net in the Condensed Consolidated Statements of Earnings. There were six open foreign currency derivative contracts, which were not designated as cash flow hedges at December 31, 2017 , with a total notional value of $71.0 . The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) December 31, 2017 September 30, 2017 Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ (1.3 ) $ (1.6 ) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ (0.7 ) $ 0.4 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended December 31, 2017 2016 Derivatives designated as cash flow hedging relationships: Foreign currency contracts (Loss) gain recognized in OCI (1) $ (0.4 ) $ 11.7 Loss (gain) reclassified from AOCI into income (effective portion) (1) (2) 0.7 0.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Loss (gain) recognized in income (2) $ 0.2 $ (3.5 ) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk. (2) Loss (gain) was recorded in Other (income) expense, net. The following table provides financial assets and liabilities for balance sheet offsetting: At December 31, 2017 At September 30, 2017 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 1.3 $ (3.3 ) $ 2.5 $ (3.7 ) Gross amounts offset in the balance sheet (0.1 ) 0.1 (0.1 ) 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 1.2 $ (3.2 ) $ 2.4 $ (3.6 ) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets. Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy: December 31, September 30, Liabilities at estimated fair value: Deferred compensation $ (57.4 ) $ (60.9 ) Derivatives - foreign currency contracts (2.0 ) (1.2 ) Net liabilities at estimated fair value $ (59.4 ) $ (62.1 ) At December 31, 2017 , the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. At December 31, 2017 and September 30, 2017 , the Company had no level 1 or level 3 financial assets or liabilities, other than pension plan assets. At December 31, 2017 and September 30, 2017 , the fair market value of fixed rate long-term debt was $1,123.0 and $1,143.8 , respectively, compared to its carrying value of $1,096.0 and $ 1,095.7 , respectively. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of variable-rate debt, excluding revolving credit facilities, which consists of bank debt, was $185.0 compared to its carrying value of $184.7 at December 31, 2017 and September 30, 2017. The estimated fair value was equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company's revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings and the revolving credit agreements have been determined based on level 2 inputs.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, if the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to the Company's financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

Segment Data

Segment Data	3 Months Ended
Segment Data	Dec. 31, 2017
Segment Reporting [Abstract]
Segment Data	Segment Data The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Bulldog® men's skin care products, Wet Ones® wipes and Playtex® household gloves until the sale of the gloves business in October 2017. Refer to Note 2 for additional details on the sale of the Playtex household gloves business. • Feminine Care includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand. • All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives, the gain on the sale of the Playtex gloves business and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance. The Company's operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and in most cases a combined sales force and management teams. The Company applies a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis. Segment net sales and profitability are presented below: Three Months Ended December 31, 2017 2016 Net Sales Wet Shave $ 294.1 $ 306.2 Sun and Skin Care 59.1 57.6 Feminine Care 82.6 89.1 All Other 32.5 32.1 Total net sales $ 468.3 $ 485.0 Segment Profit Wet Shave $ 54.7 $ 72.0 Sun and Skin Care (6.1 ) 0.8 Feminine Care 5.0 8.3 All Other 7.2 6.9 Total segment profit 60.8 88.0 General corporate and other expenses (18.4 ) (16.4 ) Gain on sale of Playtex gloves 15.9 — Restructuring and related costs (1) — (7.2 ) Amortization of intangibles (4.4 ) (4.0 ) Interest and other expense, net (20.8 ) (15.5 ) Total earnings before income taxes $ 33.1 $ 44.9 (1) Includes pre-tax Cost of products sold of $0.3 for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring. Supplemental product information is presented below for net sales: Three Months Ended 2017 2016 Razors and blades $ 261.5 $ 271.3 Tampons, pads and liners 82.6 89.1 Sun care products 38.3 37.7 Shaving gels and creams 32.6 34.9 Infant care and other 32.5 32.1 Skin care products 20.8 19.9 Total net sales $ 468.3 $ 485.0

Guarantor and Non-Guarantor Fin

Guarantor and Non-Guarantor Financial Information	3 Months Ended
Guarantor and Non-Guarantor Financial Information	Dec. 31, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Guarantor and Non-Guarantor Financial Information	Guarantor and Non-Guarantor Financial Information The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture. Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of the Parent Company, Edgewell Personal Care Company, the Guarantors on a combined basis, the Non-Guarantors on a combined basis and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 312.1 $ 227.5 $ (71.3 ) $ 468.3 Cost of products sold — 194.8 144.5 (71.3 ) 268.0 Gross profit — 117.3 83.0 — 200.3 Selling, general and administrative expense — 61.9 35.3 — 97.2 Advertising and sales promotion expense — 26.5 22.5 — 49.0 Research and development expense — 16.1 — — 16.1 Gain on sale of Playtex gloves — (15.9 ) — — (15.9 ) Interest expense associated with debt 13.4 4.2 0.2 — 17.8 Other expense, net — 0.4 2.6 — 3.0 Intercompany service fees — (6.9 ) 6.9 — — Equity in earnings of subsidiaries (16.5 ) (12.8 ) — 29.3 — Earnings before income taxes 3.1 43.8 15.5 (29.3 ) 33.1 Income tax (benefit) provision (3.6 ) 27.3 2.7 — 26.4 Net earnings $ 6.7 $ 16.5 $ 12.8 $ (29.3 ) $ 6.7 Statements of Comprehensive Income: Net earnings $ 6.7 $ 16.5 $ 12.8 $ (29.3 ) $ 6.7 Other comprehensive income, net of tax 10.1 10.1 9.6 (19.7 ) 10.1 Total comprehensive income $ 16.8 $ 26.6 $ 22.4 $ (49.0 ) $ 16.8 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 342.9 $ 232.3 $ (90.2 ) $ 485.0 Cost of products sold — 204.5 142.7 (90.2 ) 257.0 Gross profit — 138.4 89.6 — 228.0 Selling, general and administrative expense — 58.7 35.1 — 93.8 Advertising and sales promotion expense — 30.2 20.4 — 50.6 Research and development expense — 16.0 0.3 — 16.3 Restructuring charges — 2.7 4.2 — 6.9 Interest expense associated with debt 13.4 3.3 0.7 — 17.4 Other expense (income), net — 0.4 (2.3 ) — (1.9 ) Intercompany service fees — (4.4 ) 4.4 — — Equity in earnings of subsidiaries (41.9 ) (21.1 ) — 63.0 — Earnings before income taxes 28.5 52.6 26.8 (63.0 ) 44.9 Income tax (benefit) provision (5.0 ) 10.9 5.5 — 11.4 Net earnings $ 33.5 $ 41.7 $ 21.3 $ (63.0 ) $ 33.5 Statements of Comprehensive Income: Net earnings 33.5 41.7 21.3 (63.0 ) 33.5 Other comprehensive (loss), net of tax (26.9 ) (3.2 ) (27.8 ) 31.0 (26.9 ) Total comprehensive income (loss) $ 6.6 $ 38.5 $ (6.5 ) $ (32.0 ) $ 6.6 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS December 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 0.6 $ 529.3 $ — $ 529.9 Trade receivables, net — 43.0 140.1 — 183.1 Inventories — 210.5 138.8 — 349.3 Other current assets — 43.0 75.3 — 118.3 Total current assets — 297.1 883.5 — 1,180.6 Investment in subsidiaries 3,657.7 1,385.7 — (5,043.4 ) — Intercompany receivables, net (1) — 849.5 51.2 (900.7 ) — Property, plant and equipment, net — 326.5 115.4 — 441.9 Goodwill — 1,061.9 385.9 — 1,447.8 Other intangible assets, net — 896.4 172.2 — 1,068.6 Other assets 1.4 0.1 32.1 — 33.6 Total assets $ 3,659.1 $ 4,817.2 $ 1,640.3 $ (5,944.1 ) $ 4,172.5 Liabilities and Shareholders' Equity Current liabilities $ 6.4 $ 234.2 $ 204.8 $ — $ 445.4 Intercompany payables, net (1) 900.7 — — (900.7 ) — Long-term debt 1,095.7 583.0 — — 1,678.7 Deferred income tax liabilities — 109.3 34.6 — 143.9 Other liabilities 0.5 233.0 15.2 — 248.7 Total liabilities 2,003.3 1,159.5 254.6 (900.7 ) 2,516.7 Total shareholders' equity 1,655.8 3,657.7 1,385.7 (5,043.4 ) 1,655.8 Total liabilities and shareholders' equity $ 3,659.1 $ 4,817.2 $ 1,640.3 $ (5,944.1 ) $ 4,172.5 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 6.4 $ 496.5 $ — $ 502.9 Trade receivables, net — 34.4 189.7 — 224.1 Inventories — 198.7 134.8 — 333.5 Other current assets — 46.3 79.4 — 125.7 Total current assets — 285.8 900.4 — 1,186.2 Investment in subsidiaries 3,554.1 1,363.2 — (4,917.3 ) — Intercompany receivables, net (1) — 644.2 54.7 (698.9 ) — Property, plant and equipment, net — 335.7 117.7 — 453.4 Goodwill — 1,061.9 384.0 — 1,445.9 Other intangible assets, net — 900.3 171.4 — 1,071.7 Other assets 1.6 0.1 29.9 — 31.6 Total assets $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 Liabilities and Shareholders' Equity Current liabilities $ 19.3 $ 259.8 $ 245.3 $ — $ 524.4 Intercompany payables, net (1) 698.9 — — (698.9 ) — Long-term debt 1,095.4 430.0 — — 1,525.4 Deferred income tax liabilities — 147.6 34.2 — 181.8 Other liabilities 0.4 199.7 15.4 — 215.5 Total liabilities 1,814.0 1,037.1 294.9 (698.9 ) 2,447.1 Total shareholders' equity 1,741.7 3,554.1 1,363.2 (4,917.3 ) 1,741.7 Total liabilities and shareholders' equity $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 117.2 $ (168.2 ) $ 30.0 $ — $ (21.0 ) Cash Flow from Investing Activities Capital expenditures — (9.2 ) (2.4 ) — (11.6 ) Playtex gloves sale — 19.0 — — 19.0 Proceeds from sale of assets — 2.1 — — 2.1 Net cash from (used by) investing activities — 11.9 (2.4 ) — 9.5 Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 253.0 — — 253.0 Cash payments on debt with original maturities greater than 90 days — (100.0 ) — — (100.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (2.5 ) 1.2 — (1.3 ) Common shares purchased (115.2 ) — — — (115.2 ) Employee shares withheld for taxes (2.0 ) — — — (2.0 ) Net cash (used by) from financing activities (117.2 ) 150.5 1.2 — 34.5 Effect of exchange rate changes on cash — — 4.0 — 4.0 Net (decrease) increase in cash and cash equivalents — (5.8 ) 32.8 — 27.0 Cash and cash equivalents, beginning of period — 6.4 496.5 — 502.9 Cash and cash equivalents, end of period $ — $ 0.6 $ 529.3 $ — $ 529.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 65.1 $ (124.8 ) $ 7.8 $ — $ (51.9 ) Cash Flow from Investing Activities Capital expenditures — (11.0 ) (2.7 ) — (13.7 ) Acquisitions, net of cash acquired — — (34.0 ) — (34.0 ) Net cash used by investing activities — (11.0 ) (36.7 ) — (47.7 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 146.0 — — 146.0 Cash payments on debt with original maturities greater than 90 days — (10.0 ) (277.0 ) — (287.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (0.9 ) 0.5 — (0.4 ) Common shares purchased (58.0 ) — — — (58.0 ) Employee shares withheld for taxes (7.1 ) — — — (7.1 ) Net cash (used by) from financing activities (65.1 ) 135.1 (276.5 ) — (206.5 ) Effect of exchange rate changes on cash — — (14.3 ) — (14.3 ) Net decrease in cash and cash equivalents — (0.7 ) (319.7 ) — (320.4 ) Cash and cash equivalents, beginning of period — 5.8 733.1 — 738.9 Cash and cash equivalents, end of period $ — $ 5.1 $ 413.4 $ — $ 418.5

Subsequent Event

Subsequent Event	3 Months Ended
Subsequent Event	Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent events	Subsequent Event On January 15, 2018, the Company entered into an agreement to acquire Jack Black, L.L.C. ("Jack Black"), a leading U.S. based luxury men's skincare products company based in Dallas, Texas. The acquisition, which is expected to close in the second quarter of fiscal 2018, will create opportunities to expand Edgewell's personal care portfolio in growing categories in the U.S. and globally, while nurturing the brand equity of Jack Black. The transaction will be funded from operating cash.

Restructuring Charges (Tables)

Restructuring Charges (Tables)	3 Months Ended
	Dec. 31, 2017
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave and Feminine Care segments for the three months ended December 31, 2016. The Company does not include restructuring costs in the results of its reportable segments. Three Months Ended December 31, 2016 Wet Feminine Total Restructuring Severance and related benefit costs $ 0.4 $ 1.5 $ 1.9 Asset impairment and accelerated depreciation — 1.7 1.7 Consulting, program management and other exit costs 1.7 1.6 3.3 Total Restructuring $ 2.1 $ 4.8 $ 6.9
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2017: Utilized October 1, 2016 Charge to Other (1) Cash Non-Cash September 30, 2017 Restructuring Severance and termination related costs $ 16.7 $ 6.5 $ (0.3 ) $ (20.5 ) $ — $ 2.4 Asset impairment and accelerated depreciation — 6.9 — — (6.9 ) — Other related costs — 16.2 — (16.2 ) — — Total Restructuring $ 16.7 $ 29.6 $ (0.3 ) $ (36.7 ) $ (6.9 ) $ 2.4 (1) Includes the impact of currency translation.	[1]

[1]	Includes the impact of currency translation.

Earnings per Share (Tables)

Earnings per Share (Tables)	3 Months Ended
Earnings per Share (Tables)	Dec. 31, 2017
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended December 31, 2017 2016 Basic weighted-average shares outstanding 55.4 57.7 Effect of dilutive securities: RSE awards 0.2 0.4 Total dilutive securities 0.2 0.4 Diluted weighted-average shares outstanding 55.6 58.1

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
Goodwill and Intangible Assets (Tables)	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Balance at October 1, 2017 $ 971.2 $ 195.6 $ 209.5 $ 69.6 $ 1,445.9 Cumulative translation adjustment 2.1 0.1 (0.3 ) — 1.9 Balance at December 31, 2017 $ 973.3 $ 195.7 $ 209.2 $ 69.6 $ 1,447.8
Schedule of Amortizable Intangible Assets	Total amortizable intangible assets were as follows: December 31, 2017 September 30, 2017 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 189.3 $ 18.3 $ 171.0 $ 188.6 $ 16.0 $ 172.6 Technology and patents 78.0 75.3 2.7 77.9 74.4 3.5 Customer related and other 151.6 91.2 60.4 151.5 89.8 61.7 Total amortizable intangible assets $ 418.9 $ 184.8 $ 234.1 $ 418.0 $ 180.2 $ 237.8

Supplemental Balance Sheet In27

Supplemental Balance Sheet Information (Tables)	3 Months Ended
Supplemental Balance Sheet Information (Tables)	Dec. 31, 2017
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	December 31, September 30, Inventories Raw materials and supplies $ 52.2 $ 50.6 Work in process 61.3 60.9 Finished products 235.8 222.0 Total inventories $ 349.3 $ 333.5 Other Current Assets Miscellaneous receivables $ 13.7 $ 16.9 Prepaid expenses 64.8 55.6 Value added tax collectible from customers 20.3 25.2 Income taxes receivable 16.7 24.7 Other 2.8 3.3 Total other current assets $ 118.3 $ 125.7 Property, Plant and Equipment Land $ 19.5 $ 19.3 Buildings 142.5 139.1 Machinery and equipment 956.3 947.4 Capitalized software costs 45.3 42.3 Construction in progress 41.8 49.7 Total gross property, plant and equipment 1,205.4 1,197.8 Accumulated depreciation and amortization (763.5 ) (744.4 ) Total property, plant and equipment, net $ 441.9 $ 453.4 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 41.4 $ 32.2 Accrued trade allowances 21.2 24.6 Accrued salaries, vacations and incentive compensation 27.1 40.6 Income taxes payable 10.6 18.3 Returns reserve 27.3 53.3 Restructuring reserve 1.7 3.0 Value added tax payable 5.1 5.8 Deferred compensation 15.3 13.8 Other 75.8 89.8 Total other current liabilities $ 225.5 $ 281.4 Other Liabilities Pensions and other retirement benefits $ 106.6 $ 109.4 Deferred compensation 42.1 47.3 Long-term income taxes payable 41.4 — Other non-current liabilities 58.6 58.8 Total other liabilities $ 248.7 $ 215.5

Debt (Tables)

Debt (Tables)	3 Months Ended
Debt (Tables)	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: December 31, September 30, Senior notes, fixed interest rate of 4.7%, due 2021, net (1) $ 598.4 $ 598.3 Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2) 497.6 497.4 U.S. revolving credit facility due 2020 398.0 245.0 Term loan, due 2019, net (1) 184.7 184.7 Total long-term debt, including current maturities 1,678.7 1,525.4 Less current portion — — Total long-term debt $ 1,678.7 $ 1,525.4 (1) At December 31, 2017 , the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.6 , $1.8 and $0.3 , respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7 , $1.9 and $0.3 , respectively. (2) At December 31, 2017 and September 30, 2017, the balance for the senior notes due 2022 was reflected net of discount of $0.6 and $0.7 , respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	3 Months Ended
Retirement Plans (Tables)	Dec. 31, 2017
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Benefit (Credit) Cost	The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows: Three Months Ended December 31, 2017 2016 Service cost $ 1.5 $ 1.8 Interest cost 4.3 3.8 Expected return on plan assets (7.9 ) (7.9 ) Recognized net actuarial loss 1.1 1.5 Settlement loss recognized — 0.3 Net periodic (benefit) cost $ (1.0 ) $ (0.5 )

Accumulated Other Comprehensi30

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive (loss) income ("AOCI"), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2017 $ (29.0 ) $ (101.3 ) $ (1.1 ) $ (131.4 ) OCI before reclassifications (1) 9.5 (0.3 ) (0.3 ) 8.9 Reclassifications to earnings — 0.7 0.5 1.2 Balance at December 31, 2017 $ (19.5 ) $ (100.9 ) $ (0.9 ) $ (121.3 ) Foreign Pension and Hedging Total Balance at October 1, 2016 $ (68.1 ) $ (126.3 ) $ (2.8 ) $ (197.2 ) OCI before reclassifications (1) (38.7 ) 2.7 7.7 (28.3 ) Reclassifications to earnings — 1.2 0.2 1.4 Balance at December 31, 2016 $ (106.8 ) $ (122.4 ) $ 5.1 $ (224.1 ) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: For the Three Months Ended Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2017 2016 Loss / (gain) on cash flow hedges Foreign exchange contracts $ 0.7 $ 0.3 Other (income) expense, net 0.7 0.3 Total before tax (0.2 ) (0.1 ) Tax expense 0.5 0.2 Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses 1.1 1.5 (1) Settlement loss recognized — 0.3 (1) 1.1 1.8 Total before tax (0.4 ) (0.6 ) Tax expense 0.7 1.2 Net of tax Total reclassifications for the period $ 1.2 $ 1.4 Net of tax (1) These AOCI components are included in the computation of net periodic (benefit) cost. See Note 10 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris31

Financial Instruments and Risk Management (Tables)	3 Months Ended
Financial Instruments and Risk Management (Tables)	Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) December 31, 2017 September 30, 2017 Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ (1.3 ) $ (1.6 ) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ (0.7 ) $ 0.4 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended December 31, 2017 2016 Derivatives designated as cash flow hedging relationships: Foreign currency contracts (Loss) gain recognized in OCI (1) $ (0.4 ) $ 11.7 Loss (gain) reclassified from AOCI into income (effective portion) (1) (2) 0.7 0.3 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Loss (gain) recognized in income (2) $ 0.2 $ (3.5 ) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk. (2) Loss (gain) was recorded in Other (income) expense, net.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: At December 31, 2017 At September 30, 2017 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 1.3 $ (3.3 ) $ 2.5 $ (3.7 ) Gross amounts offset in the balance sheet (0.1 ) 0.1 (0.1 ) 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 1.2 $ (3.2 ) $ 2.4 $ (3.6 ) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy: December 31, September 30, Liabilities at estimated fair value: Deferred compensation $ (57.4 ) $ (60.9 ) Derivatives - foreign currency contracts (2.0 ) (1.2 ) Net liabilities at estimated fair value $ (59.4 ) $ (62.1 )

Segment Data (Tables)

Segment Data (Tables)	3 Months Ended
Segment Data (Tables)	Dec. 31, 2017
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended December 31, 2017 2016 Net Sales Wet Shave $ 294.1 $ 306.2 Sun and Skin Care 59.1 57.6 Feminine Care 82.6 89.1 All Other 32.5 32.1 Total net sales $ 468.3 $ 485.0 Segment Profit Wet Shave $ 54.7 $ 72.0 Sun and Skin Care (6.1 ) 0.8 Feminine Care 5.0 8.3 All Other 7.2 6.9 Total segment profit 60.8 88.0 General corporate and other expenses (18.4 ) (16.4 ) Gain on sale of Playtex gloves 15.9 — Restructuring and related costs (1) — (7.2 ) Amortization of intangibles (4.4 ) (4.0 ) Interest and other expense, net (20.8 ) (15.5 ) Total earnings before income taxes $ 33.1 $ 44.9 (1) Includes pre-tax Cost of products sold of $0.3 for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended 2017 2016 Razors and blades $ 261.5 $ 271.3 Tampons, pads and liners 82.6 89.1 Sun care products 38.3 37.7 Shaving gels and creams 32.6 34.9 Infant care and other 32.5 32.1 Skin care products 20.8 19.9 Total net sales $ 468.3 $ 485.0

Guarantor and Non-Guarantor F33

Guarantor and Non-Guarantor Financial Information (Tables)	3 Months Ended
Guarantor and Non-Guarantor Financial Information (Tables)	Dec. 31, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 312.1 $ 227.5 $ (71.3 ) $ 468.3 Cost of products sold — 194.8 144.5 (71.3 ) 268.0 Gross profit — 117.3 83.0 — 200.3 Selling, general and administrative expense — 61.9 35.3 — 97.2 Advertising and sales promotion expense — 26.5 22.5 — 49.0 Research and development expense — 16.1 — — 16.1 Gain on sale of Playtex gloves — (15.9 ) — — (15.9 ) Interest expense associated with debt 13.4 4.2 0.2 — 17.8 Other expense, net — 0.4 2.6 — 3.0 Intercompany service fees — (6.9 ) 6.9 — — Equity in earnings of subsidiaries (16.5 ) (12.8 ) — 29.3 — Earnings before income taxes 3.1 43.8 15.5 (29.3 ) 33.1 Income tax (benefit) provision (3.6 ) 27.3 2.7 — 26.4 Net earnings $ 6.7 $ 16.5 $ 12.8 $ (29.3 ) $ 6.7 Statements of Comprehensive Income: Net earnings $ 6.7 $ 16.5 $ 12.8 $ (29.3 ) $ 6.7 Other comprehensive income, net of tax 10.1 10.1 9.6 (19.7 ) 10.1 Total comprehensive income $ 16.8 $ 26.6 $ 22.4 $ (49.0 ) $ 16.8 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended December 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 342.9 $ 232.3 $ (90.2 ) $ 485.0 Cost of products sold — 204.5 142.7 (90.2 ) 257.0 Gross profit — 138.4 89.6 — 228.0 Selling, general and administrative expense — 58.7 35.1 — 93.8 Advertising and sales promotion expense — 30.2 20.4 — 50.6 Research and development expense — 16.0 0.3 — 16.3 Restructuring charges — 2.7 4.2 — 6.9 Interest expense associated with debt 13.4 3.3 0.7 — 17.4 Other expense (income), net — 0.4 (2.3 ) — (1.9 ) Intercompany service fees — (4.4 ) 4.4 — — Equity in earnings of subsidiaries (41.9 ) (21.1 ) — 63.0 — Earnings before income taxes 28.5 52.6 26.8 (63.0 ) 44.9 Income tax (benefit) provision (5.0 ) 10.9 5.5 — 11.4 Net earnings $ 33.5 $ 41.7 $ 21.3 $ (63.0 ) $ 33.5 Statements of Comprehensive Income: Net earnings 33.5 41.7 21.3 (63.0 ) 33.5 Other comprehensive (loss), net of tax (26.9 ) (3.2 ) (27.8 ) 31.0 (26.9 ) Total comprehensive income (loss) $ 6.6 $ 38.5 $ (6.5 ) $ (32.0 ) $ 6.6
Schedule of Condensed Consolidating Balance Sheets	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS December 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 0.6 $ 529.3 $ — $ 529.9 Trade receivables, net — 43.0 140.1 — 183.1 Inventories — 210.5 138.8 — 349.3 Other current assets — 43.0 75.3 — 118.3 Total current assets — 297.1 883.5 — 1,180.6 Investment in subsidiaries 3,657.7 1,385.7 — (5,043.4 ) — Intercompany receivables, net (1) — 849.5 51.2 (900.7 ) — Property, plant and equipment, net — 326.5 115.4 — 441.9 Goodwill — 1,061.9 385.9 — 1,447.8 Other intangible assets, net — 896.4 172.2 — 1,068.6 Other assets 1.4 0.1 32.1 — 33.6 Total assets $ 3,659.1 $ 4,817.2 $ 1,640.3 $ (5,944.1 ) $ 4,172.5 Liabilities and Shareholders' Equity Current liabilities $ 6.4 $ 234.2 $ 204.8 $ — $ 445.4 Intercompany payables, net (1) 900.7 — — (900.7 ) — Long-term debt 1,095.7 583.0 — — 1,678.7 Deferred income tax liabilities — 109.3 34.6 — 143.9 Other liabilities 0.5 233.0 15.2 — 248.7 Total liabilities 2,003.3 1,159.5 254.6 (900.7 ) 2,516.7 Total shareholders' equity 1,655.8 3,657.7 1,385.7 (5,043.4 ) 1,655.8 Total liabilities and shareholders' equity $ 3,659.1 $ 4,817.2 $ 1,640.3 $ (5,944.1 ) $ 4,172.5 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 6.4 $ 496.5 $ — $ 502.9 Trade receivables, net — 34.4 189.7 — 224.1 Inventories — 198.7 134.8 — 333.5 Other current assets — 46.3 79.4 — 125.7 Total current assets — 285.8 900.4 — 1,186.2 Investment in subsidiaries 3,554.1 1,363.2 — (4,917.3 ) — Intercompany receivables, net (1) — 644.2 54.7 (698.9 ) — Property, plant and equipment, net — 335.7 117.7 — 453.4 Goodwill — 1,061.9 384.0 — 1,445.9 Other intangible assets, net — 900.3 171.4 — 1,071.7 Other assets 1.6 0.1 29.9 — 31.6 Total assets $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 Liabilities and Shareholders' Equity Current liabilities $ 19.3 $ 259.8 $ 245.3 $ — $ 524.4 Intercompany payables, net (1) 698.9 — — (698.9 ) — Long-term debt 1,095.4 430.0 — — 1,525.4 Deferred income tax liabilities — 147.6 34.2 — 181.8 Other liabilities 0.4 199.7 15.4 — 215.5 Total liabilities 1,814.0 1,037.1 294.9 (698.9 ) 2,447.1 Total shareholders' equity 1,741.7 3,554.1 1,363.2 (4,917.3 ) 1,741.7 Total liabilities and shareholders' equity $ 3,555.7 $ 4,591.2 $ 1,658.1 $ (5,616.2 ) $ 4,188.8 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
Schedule of Condensed Consolidating Statements of Cash Flows	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 117.2 $ (168.2 ) $ 30.0 $ — $ (21.0 ) Cash Flow from Investing Activities Capital expenditures — (9.2 ) (2.4 ) — (11.6 ) Playtex gloves sale — 19.0 — — 19.0 Proceeds from sale of assets — 2.1 — — 2.1 Net cash from (used by) investing activities — 11.9 (2.4 ) — 9.5 Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 253.0 — — 253.0 Cash payments on debt with original maturities greater than 90 days — (100.0 ) — — (100.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (2.5 ) 1.2 — (1.3 ) Common shares purchased (115.2 ) — — — (115.2 ) Employee shares withheld for taxes (2.0 ) — — — (2.0 ) Net cash (used by) from financing activities (117.2 ) 150.5 1.2 — 34.5 Effect of exchange rate changes on cash — — 4.0 — 4.0 Net (decrease) increase in cash and cash equivalents — (5.8 ) 32.8 — 27.0 Cash and cash equivalents, beginning of period — 6.4 496.5 — 502.9 Cash and cash equivalents, end of period $ — $ 0.6 $ 529.3 $ — $ 529.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended December 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 65.1 $ (124.8 ) $ 7.8 $ — $ (51.9 ) Cash Flow from Investing Activities Capital expenditures — (11.0 ) (2.7 ) — (13.7 ) Acquisitions, net of cash acquired — — (34.0 ) — (34.0 ) Net cash used by investing activities — (11.0 ) (36.7 ) — (47.7 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 146.0 — — 146.0 Cash payments on debt with original maturities greater than 90 days — (10.0 ) (277.0 ) — (287.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (0.9 ) 0.5 — (0.4 ) Common shares purchased (58.0 ) — — — (58.0 ) Employee shares withheld for taxes (7.1 ) — — — (7.1 ) Net cash (used by) from financing activities (65.1 ) 135.1 (276.5 ) — (206.5 ) Effect of exchange rate changes on cash — — (14.3 ) — (14.3 ) Net decrease in cash and cash equivalents — (0.7 ) (319.7 ) — (320.4 ) Cash and cash equivalents, beginning of period — 5.8 733.1 — 738.9 Cash and cash equivalents, end of period $ — $ 5.1 $ 413.4 $ — $ 418.5

Background and Basis of Prese34

Background and Basis of Presentation (Details) $ in Millions	3 Months Ended
	Dec. 31, 2017USD ($)brandscountry	Dec. 31, 2016USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of brands \| brands	25
Number of countries in which Edgewell operates \| country	50
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision	$ 26.4	$ 11.4
Employee shares withheld for taxes	2	7.1
Accounting Standards Update 2016-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision	0.6
Deferred tax assets	$ 9.7
Employee shares withheld for taxes		$ 7.1

Divestiture (Narrative) (Detail

Divestiture (Narrative) (Details) - USD ($) $ in Millions	Oct. 03, 2017	Dec. 31, 2017	Dec. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Playtex gloves sale		$ (19)	$ 0
Playtex gloves \| Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Playtex gloves sale	$ 19
Value of disposed assets	3.1
Gain on disposal	$ 15.9

Restructuring Charges (Narrativ

Restructuring Charges (Narrative) (Details) - USD ($) $ in Millions		3 Months Ended		12 Months Ended	59 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs	[1]	$ 0	$ 7.2
Restructuring charges		0	6.9
Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges incurred to date					$ 170.1
Restructuring charges			6.9	$ 29.6
Restructuring reserve		0		2.4	2.4	$ 16.7
Inventory obsolescence \| Cost of products sold \| Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs			$ 0.3
Severance and termination related costs \| Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges				6.5
Restructuring reserve				$ 2.4	$ 2.4	$ 16.7
Severance and termination related costs \| Selling, general and administrative expenses \| Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 0

[1]	Includes pre-tax Cost of products sold of $0.3 for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017
Restructuring Cost and Reserve [Line Items]
Total Restructuring	$ 0	$ 6.9
Restructuring
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		1.9
Asset impairment and accelerated depreciation		1.7
Consulting, program management and other exit costs		3.3
Total Restructuring		6.9	$ 29.6
Restructuring \| Wet Shave
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0.4
Asset impairment and accelerated depreciation		0
Consulting, program management and other exit costs		1.7
Total Restructuring		2.1
Restructuring \| Feminine Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		1.5
Asset impairment and accelerated depreciation		1.7
Consulting, program management and other exit costs		1.6
Total Restructuring		$ 4.8

Restructuring Charges (Schedu38

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($) $ in Millions		3 Months Ended		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017
Restructuring Reserve [Roll Forward]
Restructuring charges		$ 0	$ 6.9
Restructuring
Restructuring Reserve [Roll Forward]
Beginning Balance		2.4	16.7	$ 16.7
Restructuring charges			6.9	29.6
Other	[1]			(0.3)
Utilized - Cash Payments				(36.7)
Utilized - Non-Cash				(6.9)
Ending Balance		0		2.4
Severance and termination related costs \| Restructuring
Restructuring Reserve [Roll Forward]
Beginning Balance		2.4	16.7	16.7
Restructuring charges				6.5
Other	[1]			(0.3)
Utilized - Cash Payments				(20.5)
Utilized - Non-Cash				0
Ending Balance				2.4
Asset impairment and accelerated depreciation \| Restructuring
Restructuring Reserve [Roll Forward]
Beginning Balance		0	0	0
Restructuring charges				6.9
Other	[1]			0
Utilized - Cash Payments				0
Utilized - Non-Cash				(6.9)
Ending Balance				0
Other related costs \| Restructuring
Restructuring Reserve [Roll Forward]
Beginning Balance		$ 0	$ 0	0
Restructuring charges				16.2
Other	[1]			0
Utilized - Cash Payments				(16.2)
Utilized - Non-Cash				0
Ending Balance				$ 0

[1]	Includes the impact of currency translation.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision	$ 26.4	$ 11.4
Federal statutory income tax rate	35.00%
Newly enacted federal tax rate	21.00%
Fiscal 2018 blended tax rate	24.50%
Earnings before income taxes	$ 33.1	$ 44.9
Effective tax rate	79.80%	25.40%
Impact of favorable tax adjustments on effective tax rate	5.00%	4.00%
Income tax provision	$ 26.4	$ 11.4
US Tax Act
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax provision	16.2
Transition tax, repatriation of foreign earnings, provision	97.2
Tax benefit, re-rate of DTAs for tax act	81
Income tax provision	$ 16.2

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	55.4	57.7
Effect of dilutive securities (in shares)	0.2	0.4
Diluted weighted-average shares outstanding (in shares)	55.6	58.1
RSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0.2	0.4

Earnings per Share (Narrative)

Earnings per Share (Narrative) (Details) shares in Millions	3 Months Ended
Earnings per Share (Narrative) (Details) shares in Millions	Dec. 31, 2017shares
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.6

Goodwill and Intangible Asset42

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) $ in Millions	3 Months Ended
	Dec. 31, 2017USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,445.9
Cumulative translation adjustment	1.9
Ending balance	1,447.8
Wet Shave
Goodwill [Roll Forward]
Beginning balance	971.2
Cumulative translation adjustment	2.1
Ending balance	973.3
Sun and Skin Care
Goodwill [Roll Forward]
Beginning balance	195.6
Cumulative translation adjustment	0.1
Ending balance	195.7
Feminine Care
Goodwill [Roll Forward]
Beginning balance	209.5
Cumulative translation adjustment	(0.3)
Ending balance	209.2
All Other
Goodwill [Roll Forward]
Beginning balance	69.6
Cumulative translation adjustment	0
Ending balance	$ 69.6

Goodwill and Intangible Asset43

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 418.9		$ 418
Amortizable intangible assets, accumulated amortization	184.8		180.2
Amortizable intangible assets, net	234.1		237.8
Amortization of intangibles	4.4	$ 4
Amortizable intangible assets, amortization expense, remainder of 2018	11.7
Amortizable intangible assets, amortization expense, fiscal 2019	14.8
Amortizable intangible assets, amortization expense, fiscal 2020	14.2
Amortizable intangible assets, amortization expense, fiscal 2021	13.6
Amortizable intangible assets, amortization expense, fiscal 2022	13.5
Amortizable intangible assets, amortization expense, fiscal 2023	13.5
Amortizable intangible assets, amortization expense, thereafter	$ 152.8
Useful life assigned to Playtex and Edge brand name (in years)	20 years
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 189.3		188.6
Amortizable intangible assets, accumulated amortization	18.3		16
Amortizable intangible assets, net	171		172.6
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	78		77.9
Amortizable intangible assets, accumulated amortization	75.3		74.4
Amortizable intangible assets, net	2.7		3.5
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	151.6		151.5
Amortizable intangible assets, accumulated amortization	91.2		89.8
Amortizable intangible assets, net	$ 60.4		$ 61.7

Goodwill and Intangible Asset44

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 834.5
Indefinite-lived intangible assets, increase	$ 0.6
Useful life assigned to Playtex and Edge brand name (in years)	20 years
Amortization of intangibles	$ 4.4	$ 4
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	185.1
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	475.7
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	29.9
All Other
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	143.8
Playtex brand name
Indefinite-lived Intangible Assets [Line Items]
Impairment charge	312
Amortization of intangibles	1.8
Edge brand name
Indefinite-lived Intangible Assets [Line Items]
Impairment charge	$ 7

Supplemental Balance Sheet In45

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2017	Sep. 30, 2017
Inventories
Raw materials and supplies	$ 52.2	$ 50.6
Work in process	61.3	60.9
Finished products	235.8	222
Total inventories	349.3	333.5
Other Current Assets
Miscellaneous receivables	13.7	16.9
Prepaid expenses	64.8	55.6
Value added tax collectible from customers	20.3	25.2
Income taxes receivable	16.7	24.7
Other	2.8	3.3
Total other current assets	118.3	125.7
Property, Plant and Equipment
Land	19.5	19.3
Buildings	142.5	139.1
Machinery and equipment	956.3	947.4
Capitalized software costs	45.3	42.3
Construction in progress	41.8	49.7
Total gross property, plant and equipment	1,205.4	1,197.8
Accumulated depreciation and amortization	(763.5)	(744.4)
Total property, plant and equipment, net	441.9	453.4
Other Current Liabilities
Accrued advertising, sales promotion and allowances	41.4	32.2
Accrued trade allowances	21.2	24.6
Accrued salaries, vacations and incentive compensation	27.1	40.6
Income taxes payable	10.6	18.3
Returns reserve	27.3	53.3
Restructuring reserve	1.7	3
Value added tax payable	5.1	5.8
Deferred compensation	15.3	13.8
Other	75.8	89.8
Total other current liabilities	225.5	281.4
Other Liabilities
Pensions and other retirement benefits	106.6	109.4
Deferred compensation	42.1	47.3
Long-term income taxes payable	41.4	0
Other non-current liabilities	58.6	58.8
Total other liabilities	$ 248.7	$ 215.5

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - Accounts receivable sales agreement - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 15, 2017
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfer of accounts receivable, max per agreement			$ 150
Transfer of accounts receivable, quarter to date sold	$ 210.1
Transfer of accounts receivable, sales amount derecognized	74.6	$ 81.7
Transfer of accounts receivable, holdback from sale	7.5	$ 8.2
Loss on sale of accounts receivable	$ 0.4

Debt (Details)

Debt (Details) - USD ($) $ in Millions		Dec. 31, 2017	Sep. 30, 2017
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 1,678.7	$ 1,525.4
Current maturities of long-term debt		0	0
Long-term debt		1,678.7	1,525.4
Notes payable		21.1	19.4
Senior notes \| Senior notes due 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]	598.4	598.3
Unamortized debt issuance costs		1.6	1.7
Senior notes \| Senior notes due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1],[2]	497.6	497.4
Unamortized debt issuance costs		1.8	1.9
Unamortized discount		0.6	0.7
Domestic line of credit
Debt Instrument [Line Items]
Total long-term debt, including current maturities		398	245
Loans payable
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]	184.7	184.7
Unamortized debt issuance costs		$ 0.3	$ 0.3

[1]	At December 31, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.6, $1.8 and $0.3, respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7, $1.9 and $0.3, respectively.
[2]	At December 31, 2017 and September 30, 2017, the balance for the senior notes due 2022 was reflected net of discount of $0.6 and $0.7, respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended
Retirement Plans (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Retirement Benefits [Abstract]
Service cost	$ 1.5	$ 1.8
Interest cost	4.3	3.8
Expected return on plan assets	(7.9)	(7.9)
Recognized net actuarial loss	1.1	1.5
Settlement loss recognized	0	0.3
Net periodic (benefit) cost	$ (1)	$ (0.5)

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2017	May 31, 2015
Stockholders' Equity Note [Abstract]
Shares authorized for repurchase (in shares)		10
Repurchase of shares (in shares)	1.9
Repurchase of shares (in usd)	$ 115.2
Cash dividends paid related to RSE award vests	$ 0.1

Accumulated Other Comprehensi50

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (131.4)	$ (197.2)
OCI before reclassifications	[1]	8.9	(28.3)
Reclassifications to earnings		1.2	1.4
Ending balance		(121.3)	(224.1)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(29)	(68.1)
OCI before reclassifications	[1]	9.5	(38.7)
Reclassifications to earnings		0	0
Ending balance		(19.5)	(106.8)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(101.3)	(126.3)
OCI before reclassifications	[1]	(0.3)	2.7
Reclassifications to earnings		0.7	1.2
Ending balance		(100.9)	(122.4)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(1.1)	(2.8)
OCI before reclassifications	[1]	(0.3)	7.7
Reclassifications to earnings		0.5	0.2
Ending balance		$ (0.9)	$ 5.1

[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi51

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2017		Dec. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings		$ (1.2)		$ (1.4)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		0.7		0.3
Gains and losses on cash flow hedges, foreign exchange contracts, tax		(0.2)		(0.1)
Gains and losses on cash flow hedges, foreign exchange contracts, after tax		0.5		0.2
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	[1]	1.1		1.5
Settlement loss recognized, before tax		0	[1]	0.3
Amortization of defined benefit pension and postretirement items, before tax		1.1		1.8
Amortization of defined benefit pension and postretirement items, tax		(0.4)		(0.6)
Amortization of defined benefit pension and postretirement items, after tax		0.7		1.2
Reclassifications to earnings		1.2		1.4
Other (income) expense, net \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ 0.7		$ 0.3

[1]	These AOCI components are included in the computation of net periodic (benefit) cost. See Note 10 of Notes to Condensed Consolidated Financial Statements

Financial Instruments and Ris52

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended
		Dec. 31, 2017USD ($)contracts	Dec. 31, 2016USD ($)	Sep. 30, 2017USD ($)
Derivative [Line Items]
Long-term debt		$ 1,678.7		$ 1,525.4
Fixed rate
Derivative [Line Items]
Long-term debt		1,096		1,095.7
Fair value of long-term debt		1,123		1,143.8
Loans payable
Derivative [Line Items]
Long-term debt	[1]	184.7		184.7
Fair value of long-term debt		$ 185		185
Not designated as hedge \| FX contract
Derivative [Line Items]
Open foreign currency contracts \| contracts		6
Notional value		$ 71
Cash flow hedge \| Designated as hedge \| FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ (1.3)		$ (1.6)
Open foreign currency contracts \| contracts		63
Notional value		$ 129.8
Other (income) expense, net \| Not designated as hedge \| FX contract
Derivative [Line Items]
Loss (gain) recognized in income	[2]	$ 0.2	$ (3.5)

[1]	At December 31, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.6, $1.8 and $0.3, respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $1.7, $1.9 and $0.3, respectively.
[2]	Loss (gain) was recorded in Other (income) expense, net.

Financial Instruments and Ris53

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Dec. 31, 2017	Sep. 30, 2017
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ (0.7)	$ 0.4
Cash flow hedge \| Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ (1.3)	$ (1.6)

[1]	All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris54

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Designated as hedge \| Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in OCI	[1]	$ (0.4)	$ 11.7
Other (income) expense, net \| Designated as hedge \| Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Loss reclassified from AOCI into income (effective portion)	[1],[2]	0.7	0.3
Other (income) expense, net \| Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Loss (gain) recognized in income	[2]	$ (0.2)	$ 3.5

[1]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.
[2]	Loss (gain) was recorded in Other (income) expense, net.

Financial Instruments and Ris55

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Dec. 31, 2017	Sep. 30, 2017
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 1.3	$ 2.5
Gross amounts of recognized liabilities	[2]	(3.3)	(3.7)
Gross amounts offset in the balance sheet	[1]	(0.1)	(0.1)
Gross amounts offset in the balance sheet	[2]	0.1	0.1
Net amounts of assets presented in the balance sheet	[1]	1.2	2.4
Net amounts of liabilities presented in the balance sheet	[2]	$ (3.2)	$ (3.6)

[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris56

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Dec. 31, 2017	Sep. 30, 2017
Derivative [Line Items]
Deferred compensation	$ (57.4)	$ (60.9)
Net liabilities at estimated fair value	(59.4)	(62.1)
FX contract
Derivative [Line Items]
Derivatives - foreign currency contracts	$ (2)	$ (1.2)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions		3 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Net sales		$ 468.3	$ 485
Gain on sale of of Playtex gloves		(15.9)	0
Restructuring and related costs	[1]	0	(7.2)
Amortization of intangibles		(4.4)	(4)
Interest and other expense, net		(20.8)	(15.5)
Earnings before income taxes		33.1	44.9
Wet Shave
Segment Reporting Information [Line Items]
Net sales		294.1	306.2
Segment profit		54.7	72
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales		59.1	57.6
Segment profit		(6.1)	0.8
Feminine Care
Segment Reporting Information [Line Items]
Net sales		82.6	89.1
Segment profit		5	8.3
All Other
Segment Reporting Information [Line Items]
Net sales		32.5	32.1
Segment profit		7.2	6.9
Operating Segments
Segment Reporting Information [Line Items]
Segment profit		60.8	88
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses		$ 18.4	16.4
Inventory obsolescence \| Restructuring \| Cost of products sold
Segment Reporting Information [Line Items]
Restructuring and related costs			$ (0.3)

[1]	Includes pre-tax Cost of products sold of $0.3 for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenue from External Customer [Line Items]
Net sales	$ 468.3	$ 485
Razors and blades
Revenue from External Customer [Line Items]
Net sales	261.5	271.3
Sun care products
Revenue from External Customer [Line Items]
Net sales	38.3	37.7
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	82.6	89.1
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	32.6	34.9
Infant care and other
Revenue from External Customer [Line Items]
Net sales	32.5	32.1
Skin care products
Revenue from External Customer [Line Items]
Net sales	$ 20.8	$ 19.9

Guarantor and Non-Guarantor F59

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Net sales	$ 468.3	$ 485
Cost of products sold	268	257
Gross profit	200.3	228
Selling, general and administrative expense	97.2	93.8
Advertising and sales promotion expense	49	50.6
Research and development expense	16.1	16.3
Gain on sale of of Playtex gloves	(15.9)	0
Restructuring charges	0	6.9
Interest expense associated with debt	17.8	17.4
Other expense (income), net	3	(1.9)
Intercompany service fees	0	0
Equity in earnings of subsidiaries	0	0
Earnings before income taxes	33.1	44.9
Income tax provision	26.4	11.4
Net earnings	6.7	33.5
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	6.7	33.5
Other comprehensive income, net of tax	10.1	(26.9)
Total comprehensive income	16.8	6.6
Eliminations
Income Statement [Abstract]
Net sales	(71.3)	(90.2)
Cost of products sold	(71.3)	(90.2)
Gross profit	0	0
Selling, general and administrative expense	0	0
Advertising and sales promotion expense	0	0
Research and development expense	0	0
Gain on sale of of Playtex gloves	0
Restructuring charges		0
Interest expense associated with debt	0	0
Other expense (income), net	0	0
Intercompany service fees	0	0
Equity in earnings of subsidiaries	29.3	63
Earnings before income taxes	(29.3)	(63)
Income tax provision	0	0
Net earnings	(29.3)	(63)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	(29.3)	(63)
Other comprehensive income, net of tax	(19.7)	31
Total comprehensive income	(49)	(32)
Parent
Income Statement [Abstract]
Net sales	0	0
Cost of products sold	0	0
Gross profit	0	0
Selling, general and administrative expense	0	0
Advertising and sales promotion expense	0	0
Research and development expense	0	0
Gain on sale of of Playtex gloves	0
Restructuring charges		0
Interest expense associated with debt	13.4	13.4
Other expense (income), net	0	0
Intercompany service fees	0	0
Equity in earnings of subsidiaries	(16.5)	(41.9)
Earnings before income taxes	3.1	28.5
Income tax provision	(3.6)	(5)
Net earnings	6.7	33.5
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	6.7	33.5
Other comprehensive income, net of tax	10.1	(26.9)
Total comprehensive income	16.8	6.6
Guarantors
Income Statement [Abstract]
Net sales	312.1	342.9
Cost of products sold	194.8	204.5
Gross profit	117.3	138.4
Selling, general and administrative expense	61.9	58.7
Advertising and sales promotion expense	26.5	30.2
Research and development expense	16.1	16
Gain on sale of of Playtex gloves	(15.9)
Restructuring charges		2.7
Interest expense associated with debt	4.2	3.3
Other expense (income), net	0.4	0.4
Intercompany service fees	(6.9)	(4.4)
Equity in earnings of subsidiaries	(12.8)	(21.1)
Earnings before income taxes	43.8	52.6
Income tax provision	27.3	10.9
Net earnings	16.5	41.7
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	16.5	41.7
Other comprehensive income, net of tax	10.1	(3.2)
Total comprehensive income	26.6	38.5
Non-Guarantors
Income Statement [Abstract]
Net sales	227.5	232.3
Cost of products sold	144.5	142.7
Gross profit	83	89.6
Selling, general and administrative expense	35.3	35.1
Advertising and sales promotion expense	22.5	20.4
Research and development expense	0	0.3
Gain on sale of of Playtex gloves	0
Restructuring charges		4.2
Interest expense associated with debt	0.2	0.7
Other expense (income), net	2.6	(2.3)
Intercompany service fees	6.9	4.4
Equity in earnings of subsidiaries	0	0
Earnings before income taxes	15.5	26.8
Income tax provision	2.7	5.5
Net earnings	12.8	21.3
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	12.8	21.3
Other comprehensive income, net of tax	9.6	(27.8)
Total comprehensive income	$ 22.4	$ (6.5)

Guarantor and Non-Guarantor F60

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Dec. 31, 2017		Sep. 30, 2017		Dec. 31, 2016	Sep. 30, 2016
Current assets
Cash and cash equivalents	$ 529.9		$ 502.9		$ 418.5	$ 738.9
Trade receivables, net	183.1		224.1
Inventories	349.3		333.5
Other current assets	118.3		125.7
Total current assets	1,180.6		1,186.2
Investment in subsidiaries	0		0
Intercompany receivables, net	0	[1]	0	[2]
Property, plant and equipment, net	441.9		453.4
Goodwill	1,447.8		1,445.9
Other intangible assets, net	1,068.6		1,071.7
Other assets	33.6		31.6
Total assets	4,172.5		4,188.8
Liabilities [Abstract]
Current liabilities	445.4		524.4
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	1,678.7		1,525.4
Deferred income tax liabilities	143.9		181.8
Other liabilities	248.7		215.5
Total liabilities	2,516.7		2,447.1
Shareholders' equity
Total shareholders' equity	1,655.8		1,741.7
Total liabilities and shareholders' equity	4,172.5		4,188.8
Eliminations
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	(5,043.4)		(4,917.3)
Intercompany receivables, net	(900.7)	[1]	(698.9)	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	0		0
Total assets	(5,944.1)		(5,616.2)
Liabilities [Abstract]
Current liabilities	0		0
Intercompany payables, net	(900.7)	[1]	(698.9)	[2]
Long-term debt	0		0
Deferred income tax liabilities	0		0
Other liabilities	0		0
Total liabilities	(900.7)		(698.9)
Shareholders' equity
Total shareholders' equity	(5,043.4)		(4,917.3)
Total liabilities and shareholders' equity	(5,944.1)		(5,616.2)
Parent
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	3,657.7		3,554.1
Intercompany receivables, net	0	[1]	0	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	1.4		1.6
Total assets	3,659.1		3,555.7
Liabilities [Abstract]
Current liabilities	6.4		19.3
Intercompany payables, net	900.7	[1]	698.9	[2]
Long-term debt	1,095.7		1,095.4
Deferred income tax liabilities	0		0
Other liabilities	0.5		0.4
Total liabilities	2,003.3		1,814
Shareholders' equity
Total shareholders' equity	1,655.8		1,741.7
Total liabilities and shareholders' equity	3,659.1		3,555.7
Guarantors
Current assets
Cash and cash equivalents	0.6		6.4		5.1	5.8
Trade receivables, net	43		34.4
Inventories	210.5		198.7
Other current assets	43		46.3
Total current assets	297.1		285.8
Investment in subsidiaries	1,385.7		1,363.2
Intercompany receivables, net	849.5	[1]	644.2	[2]
Property, plant and equipment, net	326.5		335.7
Goodwill	1,061.9		1,061.9
Other intangible assets, net	896.4		900.3
Other assets	0.1		0.1
Total assets	4,817.2		4,591.2
Liabilities [Abstract]
Current liabilities	234.2		259.8
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	583		430
Deferred income tax liabilities	109.3		147.6
Other liabilities	233		199.7
Total liabilities	1,159.5		1,037.1
Shareholders' equity
Total shareholders' equity	3,657.7		3,554.1
Total liabilities and shareholders' equity	4,817.2		4,591.2
Non-Guarantors
Current assets
Cash and cash equivalents	529.3		496.5		$ 413.4	$ 733.1
Trade receivables, net	140.1		189.7
Inventories	138.8		134.8
Other current assets	75.3		79.4
Total current assets	883.5		900.4
Investment in subsidiaries	0		0
Intercompany receivables, net	51.2	[1]	54.7	[2]
Property, plant and equipment, net	115.4		117.7
Goodwill	385.9		384
Other intangible assets, net	172.2		171.4
Other assets	32.1		29.9
Total assets	1,640.3		1,658.1
Liabilities [Abstract]
Current liabilities	204.8		245.3
Intercompany payables, net	0	[1]	0	[2]
Long-term debt	0		0
Deferred income tax liabilities	34.6		34.2
Other liabilities	15.2		15.4
Total liabilities	254.6		294.9
Shareholders' equity
Total shareholders' equity	1,385.7		1,363.2
Total liabilities and shareholders' equity	$ 1,640.3		$ 1,658.1

[1]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
[2]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

Guarantor and Non-Guarantor F61

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flow from Operating Activities
Net cash flow from (used by) operations	$ (21)	$ (51.9)
Cash Flow from Investing Activities
Capital expenditures	(11.6)	(13.7)
Acquisitions, net of cash acquired	0	(34)
Proceeds from sale of assets	2.1	0
Net cash from (used by) investing activities	9.5	(47.7)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	253	146
Cash payments on debt with original maturities greater than 90 days	(100)	(287)
Net decrease in debt with original maturities of 90 days or less	(1.3)	(0.4)
Common shares purchased	(115.2)	(58)
Employee shares withheld for taxes	(2)	(7.1)
Net cash (used by) from financing activities	34.5	(206.5)
Effect of exchange rate changes on cash	4	(14.3)
Net (decrease) increase in cash and cash equivalents	27	(320.4)
Cash and cash equivalents, beginning of period	502.9	738.9
Cash and cash equivalents, end of period	529.9	418.5
Eliminations
Cash Flow from Operating Activities
Net cash flow from (used by) operations	0	0
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired		0
Proceeds from sale of assets	0
Net cash from (used by) investing activities	0	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net decrease in debt with original maturities of 90 days or less	0	0
Common shares purchased	0	0
Employee shares withheld for taxes	0	0
Net cash (used by) from financing activities	0	0
Effect of exchange rate changes on cash	0	0
Net (decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Parent
Cash Flow from Operating Activities
Net cash flow from (used by) operations	117.2	65.1
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired		0
Proceeds from sale of assets	0
Net cash from (used by) investing activities	0	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net decrease in debt with original maturities of 90 days or less	0	0
Common shares purchased	(115.2)	(58)
Employee shares withheld for taxes	(2)	(7.1)
Net cash (used by) from financing activities	(117.2)	(65.1)
Effect of exchange rate changes on cash	0	0
Net (decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	(168.2)	(124.8)
Cash Flow from Investing Activities
Capital expenditures	(9.2)	(11)
Acquisitions, net of cash acquired		0
Proceeds from sale of assets	2.1
Net cash from (used by) investing activities	11.9	(11)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	253	146
Cash payments on debt with original maturities greater than 90 days	(100)	(10)
Net decrease in debt with original maturities of 90 days or less	(2.5)	(0.9)
Common shares purchased	0	0
Employee shares withheld for taxes	0	0
Net cash (used by) from financing activities	150.5	135.1
Effect of exchange rate changes on cash	0	0
Net (decrease) increase in cash and cash equivalents	(5.8)	(0.7)
Cash and cash equivalents, beginning of period	6.4	5.8
Cash and cash equivalents, end of period	0.6	5.1
Non-Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	30	7.8
Cash Flow from Investing Activities
Capital expenditures	(2.4)	(2.7)
Acquisitions, net of cash acquired		(34)
Proceeds from sale of assets	0
Net cash from (used by) investing activities	(2.4)	(36.7)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	(277)
Net decrease in debt with original maturities of 90 days or less	1.2	0.5
Common shares purchased	0	0
Employee shares withheld for taxes	0	0
Net cash (used by) from financing activities	1.2	(276.5)
Effect of exchange rate changes on cash	4	(14.3)
Net (decrease) increase in cash and cash equivalents	32.8	(319.7)
Cash and cash equivalents, beginning of period	496.5	733.1
Cash and cash equivalents, end of period	529.3	$ 413.4
Playtex gloves
Cash Flow from Investing Activities
Proceeds from sale of assets	19
Playtex gloves \| Eliminations
Cash Flow from Investing Activities
Proceeds from sale of assets	0
Playtex gloves \| Parent
Cash Flow from Investing Activities
Proceeds from sale of assets	0
Playtex gloves \| Guarantors
Cash Flow from Investing Activities
Proceeds from sale of assets	19
Playtex gloves \| Non-Guarantors
Cash Flow from Investing Activities
Proceeds from sale of assets	$ 0